A Review on: - Losartan in Hypertension and Heart Failure: Pharmacovigilance and Adverse Drug Monitoring

Reference

1. Burnier M. Angiotensin II receptor blockers. Circulation. 2001;103(6):904–912.
2. Bangalore S, Kumar S, Kjeldsen SE, et al. Angiotensin receptor blockers in hypertension. Am J Med. 2011;124(9):877–892.
3. Indian Pharmacopoeia Commission. Pharmacovigilance Programme of India. https://ipc.gov.in
4. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline on hypertension. J Am Coll Cardiol. 2018;71(19): e127–e248.
5. Malhotra S, Shafiq N, Pandhi P. Drug safety monitoring in India. Pharmacoepidemiol Drug Saf. 2007;16(7):684–689.
6. Arora D, Jalali RK, Vohora D. Relevance of pharmacovigilance. Asian J Pharm Clin Res. 2011;4(1):1–5.
7. WHO Uppsala Monitoring Centre. VigiBase – Global ICSR Database. https://who-umc.org.
8. Palanisamy S, Arul Kumaran KSG, Rajasekaran A. ADR monitoring in Indian hospitals. Asian J Pharm Clin Res. 2011;4(3):112–116.
9. FDA. Losartan (Cozaar) – Label Information. https://www.accessdata.fda.gov.
10. Loke YK, Golder SP, Chan M. Serious adverse events with common drugs. PLoS Med. 2011;8(5): e1000433.
11. Pitt B, Segal R, Martinez FA, et al. Losartan in heart failure. Lancet. 1997; 349:747–752.
12. Dahlöf B, et al. Losartan vs atenolol in hypertension (LIFE study). Lancet. 2002; 359:995–1003.
13. Cohn JN, et al. Angiotensin receptor blockers in heart failure. N Engl J Med. 2001; 345:1667–1675.
14. Brenner BM, et al. Renal outcomes with Losartan in diabetes (RENAAL). N Engl J Med. 2001; 345:861–869.
15. Mann JF, et al. Losartan in diabetic nephropathy. Kidney Int. 2004;66(3):1132–1139.
16. Turnbull F, et al. Effects of different blood pressure-lowering regimens. Lancet. 2003; 362:1527–1535.
17. Kostis JB, et al. Incidence of cough with ARBs vs ACEIs. J Clin Hypertens. 2005;7(11):713–716.
18. Iwai N, et al. Genetics of response to ARBs. Hypertension. 2004;43(6):1161–1169.
19. Touyz RM. ARBs and vascular protection. Cardiovasc Res. 2005;65(4):773–782.
20. McMurray JJ, et al. Guidelines on heart failure management. Eur Heart J. 2012;33(14):1787–1847.